A waveguide neural interface device including: a neural device implantable in tissue and including an array of electrode sites that electrically communicate with their surroundings, in which the array of electrode sites includes at least one recording electrode site; and a waveguide, coupled to the neural device, that carries light along a longitudinal axis and includes a light directing element that redirects the carried light from the waveguide to illuminate selectively targeted tissue, in which at least a portion of the redirected light is directed laterally away from the longitudinal axis and the recording electrode site is configured to sample illuminated tissue. A method for assembling a waveguide neural interface device is also described.
|
1. A waveguide neural interface device, comprising:
a) a neural device configured for implanting in tissue and comprises a neural device sidewall extending from a proximal neural device portion that is connectable to a pulse generator to a distal neural device portion;
b) an array of electrode sites supported by the neural device sidewall, wherein the array of electrode sites are configured to electrically communicate with their surroundings and comprises at least one recording electrode site located on a first face of the distal neural device portion;
c) a first waveguide extending from a proximal first waveguide portion that is connectable to a light source to a distal first waveguide portion having a distal first waveguide end, wherein the distal first waveguide portion is supported by a second face of the distal neural device portion;
d) an aperture extending from the first face through the neural device sidewall to the second face in the distal neural device portion; and
e) a light redirecting element supported by the distal first waveguide portion adjacent to the aperture,
f) wherein the light redirecting element serves to redirect light traveling along the distal first waveguide portion through the aperture in the neural device portion to thereby illuminate selectively targeted tissue adjacent to, but in a manner that avoids direct illumination of, the at least one recording electrode site on the first face of the distal neural device portion, and wherein the at least one recording electrode site is configured to sample illuminated tissue.
44. A waveguide neural interface device, comprising:
a) a neural device configured for implanting in tissue and comprises a neural device sidewall extending from a proximal neural device portion that is connectable to a pulse generator to a distal neural device portion, wherein at least the distal neural device portion extends along a first longitudinal axis;
b) an array of electrode sites supported by the neural device sidewall, wherein the array of electrode sites are configured to electrically communicate with their surroundings and include at least one recording electrode site located on a first face of the distal neural device portion;
c) a first waveguide extending from a proximal first waveguide portion that is connectable to a light source to a distal first waveguide portion having a distal first waveguide end, wherein the distal first waveguide portion extends along a second longitudinal axis and is supported by a second face of the distal neural device portion in a side-by-side, coaxial relationship;
d) a first aperture extending from the first face through the neural device sidewall to the second face in the distal neural device portion; and
e) a light redirecting element supported by the distal first waveguide portion adjacent to the first aperture,
f) wherein the light redirecting element serves to redirect light traveling along the distal first waveguide portion away from the second longitudinal axis and through the first aperture in the neural device sidewall to thereby illuminate selectively targeted tissue adjacent to, but in a manner that avoids direct illumination of, the at least one recording electrode site on the first face of the distal neural device portion, and wherein the at least one recording electrode site is configured to sample illuminated tissue.
73. A waveguide neural interface device, comprising:
a) a neural device configured for implanting in tissue and comprises a neural device sidewall extending from a proximal neural device portion that is connectable to a pulse generator to a distal neural device portion, wherein at least the distal neural device portion extends along a first longitudinal axis;
b) an array of electrode sites supported by the neural device sidewall, wherein the array of electrode sites are configured to electrically communicate with their surroundings and include at least one recording electrode site located on a first face of the distal neural device portion;
c) a waveguide extending from a proximal waveguide portion that is connectable to a light source to a distal waveguide portion having a distal waveguide end, wherein the distal waveguide portion extends along a second longitudinal axis and is supported by a second face of the distal neural device portion in a side-by-side, co-axial relationship;
d) an aperture extending from the first face through the neural device sidewall to the second face in the distal neural device portion;
e) a double-faced circuit board that includes an electrical face having electrical components that interface with the at least one recording electrode site and an optical face having components that interface with the waveguide; and
f) a light redirecting element supported by the distal first waveguide portion adjacent to the aperture,
g) wherein the light redirecting element serves to redirect light traveling along the distal first waveguide portion away from the second longitudinal axis and through the aperture in the neural device sidewall to thereby illuminate selectively targeted tissue adjacent to, but in a manner that avoids direct illumination of, the at least one recording electrode site on the first face of the distal neural device portion, and
h) wherein the at least one recording electrode site is configured to sample illuminated tissue and the circuit-board is configured to transmit information recorded by the recording electrode site to the proximal neural device portion.
3. The waveguide neural interface device of
4. The waveguide neural interface device of
5. The waveguide neural interface device of
6. The waveguide neural interface device of
7. The waveguide neural interface device of
8. The waveguide neural interface device of
9. The waveguide neural interface device of
10. The waveguide neural interface of
11. The waveguide neural interface device of
12. The waveguide neural interface device of
13. The waveguide neural interface device of
14. The waveguide neural interface device of
15. The waveguide neural interface device of
16. The waveguide neural interface device of
17. The waveguide neural interface device of
18. The waveguide neural interface device of
20. The waveguide neural interface device of
21. The waveguide neural interface device of
22. The waveguide neural interface device of
23. The waveguide neural interface device of
24. The waveguide neural interface device of
25. The waveguide neural interface device of
26. The waveguide neural interface device of
27. The waveguide neural interface device of
28. The waveguide neural interface device of
29. The waveguide neural interface device of
30. The waveguide neural interface device of
31. The waveguide neural interface device of
32. The waveguide neural interface device of
33. The waveguide neural interface device of
34. The waveguide neural interface device of
35. The waveguide neural interface device of
36. The waveguide neural interface device of
37. The waveguide neural interface device of
38. The waveguide neural interface device of
39. The waveguide neural interface device of
40. The waveguide neural interface device of
41. The waveguide neural interface device of
42. The waveguide neural interface device of
43. The waveguide neural interface device of
46. The waveguide neural interface device of
47. The waveguide neural interface device of
48. The waveguide neural interface device of
49. The waveguide neural interface device of
50. The waveguide neural interface device of
51. The waveguide neural interface device of
52. The waveguide neural interface device of
53. The waveguide neural interface device of
54. The waveguide neural interface device of
55. The waveguide neural interface device of
56. The waveguide neural interface device of
57. The waveguide neural interface device of
58. The waveguide neural interface device of
59. The waveguide neural interface device of
60. The waveguide neural interface device of
61. The waveguide neural interface device of
62. The waveguide neural interface device of
63. The waveguide neural interface device of
64. The waveguide neural interface device of
65. The waveguide neural interface device of
66. The waveguide neural interface device of
67. The waveguide neural interface device of
68. The waveguide neural interface device of
69. The waveguide neural interface device of
70. The waveguide neural interface device of
71. The waveguide neural interface device of
72. The waveguide neural interface device of
74. The waveguide neural interface device of
75. The waveguide neural interface device of
|
This application claims the benefit of U.S. Provisional Applications Nos. 61/258,494 filed 5 Nov. 2009 and 61/321,089 filed 5 Apr. 2010, which are both incorporated in their entirety by this reference.
This invention relates generally to the neural device field, and more specifically to an improved waveguide neural interface device in the neural device field.
Advances in neuroscience have largely depended on the advance of technology, which continually provides new methods to perturb neural circuits and measure the circuit's response. One recent advance is the use of optogenetic tools to perturb neural circuits, particularly neural circuits with cell-type specificity. Optogenetics creates light-sensitive ion channels for optical stimulation of neural assemblies, and therefore allow experimenters or medical practitioners to selectively excite neural channels and/or inhibit other neural channels with high precision. Optogenetic technology is driving demand for new techniques and products to couple light stimulation with high-density neural recordings. Intracortical opto-electrical devices or “optrodes” provide the ultimate combination of perturbation and monitoring capabilities. However, the technology and application of conventional optrode devices are raw and inefficient. Commercial systems are not available and current techniques have limitations in most experiments. For instance, many neuroscientists modify commercially available optical fibers for use in their optogenetic studies, but these have drawbacks that limit practical applications, including having only one-dimensional light output, and being brittle and dangerous due to being made of fused silica. Furthermore, an electrical artifact, known as the Becquerel or photoelectrochemical effect, arises when an electrode is placed in a conductive medium and illuminated even at low intensity. In the Becquerel effect, incident light produces a current that affects low frequency potentials, thereby confounding some neural recording applications.
Thus, there is a need in the neural interface field, which includes the clinical treatment of neurological disorders, to create an improved waveguide neural interface device. This invention provides such an improved waveguide neural interface device.
The following description of preferred embodiments of the invention is not intended to limit the invention to these preferred embodiments, but rather to enable any person skilled in the art to make and use this invention. As used herein and unless stated otherwise, the term “dissipation” (and its derivatives) is used to refer to the dissipation of light as a result of diffusion, scattering (e.g., single event scattering or multiple event scattering), or any suitable emission or redirection of light.
1. Waveguide Neural Interface Device of a First Preferred Embodiment
As shown in
The neural device 110 functions to provide structure for the array of electrode sites 112, and in some cases, for insertion and/or implantation of the waveguide neural interface device into tissue. The neural device 110 may be a neural probe such as that described in U.S. Patent Application number 2008/0208283, which is included in its entirety by this reference. Alternatively, the neural device 110 may be any suitable neural probe or suitable structure. As shown in
The waveguide 120 functions to redirect light away from the waveguide neural interface device to optically stimulate targeted tissue. In some embodiments, as shown in
As shown in
In a first variation, as shown in
In a second variation, as shown in
In a third variation, as shown in
In a fourth variation, the light directing element 122 includes a scattering element that scatters carried light away from the waveguide 120 or back along the longitudinal axis, in applications similar to the reflector. The scattering element may include a distributed Bragg reflector, surface corrugations, an optically dissipating coating, optically dissipating molecules embedded in the waveguide 120, and/or any suitable kind of scattering element. The light directing element may further include any suitable number of scattering elements.
The waveguide 120 may include one or more light directing elements 122, and where there are multiple light directing elements, the light directing elements may be one or more of the variations in any suitable combination. Furthermore, the waveguide 120 may include an arrangement of a plurality of light directing elements longitudinally and/or laterally along the waveguide in any suitable pattern, thereby distributing carried light away from the waveguide in any suitable manner. Each light directing element may redirect a portion of the carried light from a different point on the waveguide. In particular, each light directing element may redirect a portion of the carried light at a different distance along the length of the waveguide.
In some variations, the waveguide 120 may further include a filter, such as one that allows only a certain bandwidth of light to pass. For example, in applications in which only a portion of illuminated tissue is configured to be stimulated by a certain color or wavelength, the filter allowing that color or wavelength to pass may consequently allow only the receptive portion of illuminated tissue to be stimulated, thereby providing another dimension of tissue targeting.
The waveguide neural interface device may include any suitable combination of the neural device 110, waveguide 120, and one or more light directing elements 122. In a first variation of the waveguide neural interface device, as shown in
In a second variation of the waveguide neural interface device, as shown in
In a third variation of the waveguide neural interface device, as shown in
Other variations of the waveguide neural interface device include any suitable combination of the above variations, such as one in which the array of electrode sites 112 is located on the front face of the neural device 110 and the waveguide 120 is both coupled to the back face of the neural device having an aperture and extends laterally beyond a portion of the neural device, such that some carried light is directed away from the waveguide 120 through the aperture and some carried light is directed away from the waveguide from the lateral extension.
The waveguide 120 is preferably formed separately from the neural device 110, and coupled to the neural device 110 during assembly as described below. However, the waveguide may alternatively be integrally formed with the neural device (such as at the wafer level during fabrication of the waveguide neural interface device).
In some embodiments, the waveguide neural interface device may include multiple branches and/or multiple waveguides configured to interface with different targeted regions of tissue. The modular integration of multiple branches, multiple waveguides, and/or multiple arrays of electrode sites enables targeting of different regions of tissue while reducing overall size and footprint of the equipment and potentially reducing external connections to a single external connection. For example, as shown in
The waveguide neural interface device preferably further includes a circuit board 130 that interfaces with at least one of the array of electrode sites 112 and the waveguide 120. As shown in
Fabrication of the waveguide 120 preferably further includes releasing the waveguide from the substrate through any suitable process, and cut to a suitable, predetermined length. The process of building, releasing, then cutting the waveguide 220 may be useful to improve modularity of the process and/or customizations of specific waveguide neural interface devices, such as for the specific customization of shape and distribution of the optically portions and dimensions of the overall waveguide. The light directing elements 122 may also be controlled and formed in the process of cutting or etching the waveguide to create various tip profiles and angles.
2. Waveguide Neural Interface Device of a Second Preferred Embodiment
As shown in
The neural device 210 of the second preferred embodiment is preferably similar to the neural device 110 of the first preferred embodiment. The neural device 210 preferably includes an electrode substrate that is layered over the waveguide 220, and the electrode substrate preferably includes at least a portion of the array of electrode sites 212.
The waveguide 220 of the second preferred embodiment of the waveguide neural device functions to redirect light away from the waveguide neural interface device to optically stimulate targeted tissue. The waveguide 220 of the second preferred embodiment of the waveguide neural interface device may be similar to that of the first preferred embodiment. The waveguide 220 may be cylindrical (e.g., an optical fiber or other cylindrical waveguide, as in
The waveguide 220 includes an inner core 230 and a cladding layer 232 over the core, and the core and cladding material are preferably selected such that the core and cladding cooperate to facilitate internal reflection. The waveguide 220 preferably undergoes photolithographic processes to pattern the cladding and selectively expose the core, such that the optically dissipating portion 222 of the waveguide includes the exposed core. However, the optically dissipating portion 222 may alternatively be formed in any suitable manner. The optically dissipating portion may include a dissipating material to further define the amount of light diffusion. The amount of light diffusion that the optically dissipating portion 222 provides is at least partially dependent on the amount of surface roughness of the core, the specific properties of the dissipating material, width of the optically dissipating portion relative to the total waveguide width, and waveguide thickness. During fabrication, many if not all of these parameters can be closely controlled, providing for precise specificity in waveguide features and detailed customization of the waveguide neural interface device for a variety of applications.
In one variation of a waveguide fabrication process, as shown in
Depositing and patterning the optically dissipating layer may alternatively be performed before depositing the upper cladding layer of cladding material. Fabrication of the waveguide 220 preferably further includes releasing the waveguide from the substrate through any suitable process, and cut to a suitable, predetermined length. The process of building, releasing, then cutting the waveguide 220 may be useful to improve modularity of the process and/or customizations of specific waveguide neural interface devices, such as for the specific customization of shape and distribution of the optically dissipating portions and dimensions of the overall waveguide. Alternatively, the final length of the waveguide 220 may be etched with another hard mask prior to release from the substrate. In some preferred embodiments, the overall length of the waveguide 220 may be between 3-400 mm long and/or up to 200 μm in thickness, depending on the application.
In one specific example, a waveguide includes a core of SU-8 (supplied by MicroChem) and cladding layers of Cytop CTL-809M (supplied by Asahi Glass). Cytop includes a lower index of refraction (n=1.34) than SU-8 (n-1.59), such that the combination of the two materials forms a waveguide with internal reflection. The sacrificial layer, lower cladding layer, core, and upper cladding layer are preferably formed as described above. The upper cladding layer is then patterned with an oxygen plasma to expose and roughen the core surface. A dissipating layer of aluminum oxide approximately 300 nm thick is sputter deposited in place of the removed upper cladding layer. The layer of aluminum oxide is then patterned using buffer hydrofluoric (HF) acid. The waveguide is then released from the wafer and diamond-scribed to a desired length. In this example, the waveguide thickness is on the order of approximately 30 μm.
In another variation of a waveguide fabrication process, as shown in
The electrode substrate of the neural device 210 is preferably layered over the waveguide 220, and more preferably in such a manner that the optically dissipating portion of the waveguide is adjacent to at least a portion of the array of electrode sites. The waveguide neural interface device may include any suitable combination of the neural device 210 and waveguide 220. As shown in
In another variation, a dissipative portion 222 may alternatively and/or additionally be deposited or otherwise integrated in the electrode substrate. In this variation, the cladding 232 is selectively removed from the waveguide but the light dissipating material may be realized in the electrode substrate and not directly on the waveguide. Alignment of the diffusive layer to the corresponding cladding occurs during assembly. A transparent adhesive may be applied to improve light coupling to the diffusive region.
In a second variation, as shown in
In a third variation, as shown in
As shown in
Additional variations of the waveguide neural interface device may include any suitable combination of the neural device 210, array of electrode sites, and waveguide 220. For example, the waveguide neural interface device may include both a light direction element of the first preferred embodiment and an optically dissipating portion of the second preferred embodiment.
In some embodiments, similar to that of the first preferred embodiment, the waveguide neural interface device of the second preferred embodiment may include multiple branches and/or multiple waveguides configured to interface with different regions of tissue, and preferably includes a circuit board that interfaces with at least one of the array of electrode sites and the waveguide. The circuit board in the second preferred embodiment is preferably similar to that of the first preferred embodiment.
3. Method of Assembling a Waveguide Neural Interface Device
As shown in
The method of making the waveguide neural interface device S300 is a modular, cost-effective approach that has several potential advantages. First, the method may provide high spatial resolution, since the waveguide can be rotated along any axis to transform a planar x-y dimension into an effective z-axis dimension that would otherwise be difficult to achieve. Second, the method may enable manufacture of custom waveguides neural interface devices that are capable of region-specific illumination, while avoiding cost and yield problems that would otherwise occur. In other words, if the waveguide and neural device are integrated at the wafer-level, then the number of desirable/useful permutations of waveguide neural interface device design is so large that it impedes the profitability of the sale of such a device. The method can overcome this problem, transcending the practical limits of a wafer-level approach. Third, the method may separate yield issues in one aspect of either the neural device or waveguide fabrication, thereby improving average yield and lowering overall cost of the final combination waveguide neural interface product. However, in alternative embodiments, the method of making the waveguide neural interface device may include any suitable steps. For example, a portion or all of the neural device, waveguide, and circuit board components may be fabricated in an integrated fashion (e.g., fabricated in sequence with any photolithographic processes and/or any suitable technique, without the post-fabrication assembly described in method 300). For example, the neural device and the waveguide may be fabricated together in sequence as an integrated structure, and then coupled to the circuit board after fabrication.
The steps of providing a neural device S310, providing a waveguide S320, and providing a circuit board S330 preferably include providing a neural device or neural probe, waveguide, and circuit board similar to those described above in the first preferred embodiment 100 and/or second preferred embodiment 200 of the waveguide neural interface device, but may alternatively include providing any suitable neural device, waveguide, and/or circuit board. Furthermore, although the method is primarily illustrated with a waveguide neural interface device of the first preferred embodiment, the method may be performed to assemble that of the second preferred embodiment (
Step S340, which includes the step of orienting the light directing element of the waveguide to a predetermined angular orientation, functions to set the direction of redirected light to a particular direction. As shown in
Step S350, which includes the step of coupling each structure of the group comprising the neural device, the waveguide, and the circuit board to at least one of the other structures in the group, functions to fix and assemble the structures of the group to form the waveguide neural interface device. Step S350 preferably includes fixing the waveguide at the predetermined angular orientation relative to the neural device and/or circuit board. In step S350, the three components (neural device, waveguide, and circuit board) may be mounted or attached in any order. In a first variation, as shown in
Step S350 of coupling may be performed manually and/or with machine assistance. One or more of the components may include features to aid component alignment, such as fiducial marks, tabs, and/or corresponding alignment holes. The steps of coupling any two of the structures may include applying an epoxy such a medical grade epoxy (e.g., Epoxy Tek H70E-2 or 320, which is designed to shield light) or a UV-curable epoxy, or using fasteners, or any suitable adhesive or other means for coupling. The steps of coupling any two of the structures may additionally and/or alternatively include applying a polymer overcoat around at least two of the structures in the group.
As a person skilled in the art will recognize from the previous detailed description and from the figures and claims, modifications and changes can be made to the preferred embodiments of the invention without departing from the scope of this invention defined in the following claims.
Kipke, Daryl R., Kong, Kc, Seymour, John P., Gulari, Mayurachat
Patent | Priority | Assignee | Title |
10016600, | May 30 2013 | NEUROSTIM SOLUTIONS, LLC | Topical neurological stimulation |
10058263, | Mar 24 2014 | University of Utah Research Foundation | Neural interface |
10307591, | May 30 2013 | NEUROSTIM SOLUTIONS, LLC | Topical neurological stimulation |
10471273, | Oct 16 2015 | California Institute of Technology | Implantable, highly collimated light-emitters for biological applications |
10625072, | Oct 21 2016 | Boston Scientific Neuromodulation Corporation | Electrical stimulation methods with optical observation and devices therefor |
10695581, | Jun 19 2015 | The Regents of the University of Michigan | Multicolor neural optoelectrode |
10918853, | May 30 2013 | NEUROSTM SOLUTIONS, LLC | Topical neurological stimulation |
10946185, | May 30 2013 | NEUROSTIM SOLUTIONS LLC | Topical neurological stimulation |
10953225, | Nov 07 2017 | NEUROSTIM OAB, INC | Non-invasive nerve activator with adaptive circuit |
11077301, | Feb 21 2015 | NEUROSTIM OAB, INC | Topical nerve stimulator and sensor for bladder control |
11229789, | May 30 2013 | NEUROSTIM OAB, INC | Neuro activator with controller |
11291828, | May 30 2013 | NEUROSTIM SOLUTIONS LLC | Topical neurological stimulation |
11458311, | Jun 26 2019 | NEUROSTIM TECHNOLOGIES LLC | Non-invasive nerve activator patch with adaptive circuit |
11730958, | Dec 16 2019 | NEUROSTIM SOLUTIONS, LLC | Non-invasive nerve activator with boosted charge delivery |
9158080, | Aug 23 2013 | Corning Incorporated | Light-coupling apparatus and methods for light-diffusing optical fibers |
9427164, | Jun 04 2011 | The Regents of the University of Michigan | Insertable neural probe with flexible structure |
9833193, | Oct 12 2012 | BRAEMAR MANUFACTURING, LLC | Monitoring device |
Patent | Priority | Assignee | Title |
3921916, | |||
4461304, | Nov 05 1979 | Massachusetts Institute of Technology | Microelectrode and assembly for parallel recording of neurol groups |
4660925, | Apr 29 1985 | MCCAUGHAN, JAMES S , JR | Apparatus for producing a cylindrical pattern of light and method of manufacture |
4904237, | May 16 1988 | Apparatus for the exchange of cerebrospinal fluid and a method of treating brain and spinal cord injuries | |
4986628, | Aug 23 1988 | RADIOTEKHNICHESY INSTITUT IMENI AKADEMIKA A L MINTSA AKADEMII NAUK SSSR | Light guide device for phototherapy |
5042980, | May 26 1989 | CARDIOFOCUS, INC | Optical fiber diffusion tip for uniform illumination |
5196005, | Nov 26 1991 | PDT Systems, Inc. | Continuous gradient cylindrical diffusion tip for optical fibers and method for making |
5207709, | Mar 01 1993 | Implant with textured surface | |
5269777, | Nov 01 1990 | PDT Systems, Inc. | Diffusion tip for optical fibers |
5308442, | Jan 25 1993 | HEWLETT-PACKARD DEVELOPMENT COMPANY, L P | Anisotropically etched ink fill slots in silicon |
5325451, | Jan 05 1993 | Motorola, Inc. | Modular optical waveguide and method for making |
5385635, | Nov 01 1993 | Xerox Corporation | Process for fabricating silicon channel structures with variable cross-sectional areas |
5546494, | Jul 08 1992 | Matsushita Electric Industrial Co., Ltd. | Optical waveguide device and manufacturing method of the same |
5548670, | Nov 27 1992 | Light-scattering light-guiding device | |
5580932, | Sep 27 1991 | Manufacturing method of a light scattering light guide | |
5585827, | Oct 29 1993 | Sony Corporation | Printer head |
5588597, | Sep 03 1993 | MicroParts GmbH | Nozzle plate for a liquid jet print head |
5721795, | May 17 1996 | Teledyne Technologies Incorporated | High efficiency ejection of light from optical wave guide, by holographically produced light scattering means |
5938694, | Nov 10 1993 | Medtronic CardioRhythm | Electrode array catheter |
5946441, | Oct 31 1995 | Indigo Medical, Inc. | Light-diffusing device for an optical fiber, methods of producing and using same, and apparatus for diffusing light from an optical fiber |
6071302, | Dec 31 1997 | CARDIOFOCUS, INC | Phototherapeutic apparatus for wide-angle diffusion |
6205361, | Feb 10 1998 | Boston Scientific Neuromodulation Corporation | Implantable expandable multicontact electrodes |
6228111, | Sep 27 1995 | Bionx Implants Oy | Biodegradable implant manufactured of polymer-based material and a method for manufacturing the same |
6374143, | Aug 18 1999 | MED-EL ELEKTRO-MEDIZINISCHE GERATE GESELLSCHAFT M B H | Modiolar hugging electrode array |
6559636, | Jun 16 1998 | Balluff, Inc. | Modular waveguide assembly and method for making the same |
6593130, | Apr 16 1999 | Regents of the University of California, The | Method and apparatus for ex vivo and in vivo cellular electroporation of gene protein or drug therapy |
6834200, | Oct 19 2000 | Drexel University | Ceramic based multi-site electrode arrays and methods for their production |
6878643, | Dec 18 2002 | Lawrence Livermore National Security LLC | Electronic unit integrated into a flexible polymer body |
6921413, | Aug 16 2000 | Vanderbilt University | Methods and devices for optical stimulation of neural tissues |
7010356, | Oct 31 2001 | National Research Council of Canada | Multichannel electrode and methods of using same |
7011680, | May 02 2001 | Boston Scientific Scimed, Inc | Stent device and method |
7076143, | Nov 04 2003 | NEC Corporation | Optical waveguide and fabricating method thereof |
7194158, | Aug 08 2003 | SCHOTT AG | Method for producing light-scattering structures on flat optical waveguides |
7260289, | Feb 11 2003 | Cisco Technology, Inc | Optical waveguide grating coupler with varying scatter cross sections |
7547551, | Jun 21 2001 | University of Antwerp | Transfection of eukaryontic cells with linear polynucleotides by electroporation |
7670838, | May 24 2004 | The Board of Trustees of the Leland Stanford Junior University | Coupling of excitation and neurogenesis in neural stem/progenitor cells |
7736382, | Sep 09 2005 | NERVESENSE LTD | Apparatus for optical stimulation of nerves and other animal tissue |
7781195, | Dec 17 1998 | University of South Florida | Electroporation device |
7937143, | Nov 02 2004 | MEDTRONIC ARDIAN LUXEMBOURG S A R L | Methods and apparatus for inducing controlled renal neuromodulation |
20020198446, | |||
20030100823, | |||
20040053873, | |||
20040106169, | |||
20040199235, | |||
20050004627, | |||
20050021117, | |||
20050137647, | |||
20050180713, | |||
20060024359, | |||
20060129210, | |||
20060192230, | |||
20060247749, | |||
20060258951, | |||
20060265014, | |||
20060276866, | |||
20060282014, | |||
20070073130, | |||
20070112404, | |||
20070123765, | |||
20070135885, | |||
20070167903, | |||
20070261127, | |||
20070270675, | |||
20080085265, | |||
20080177363, | |||
20080208283, | |||
20080227139, | |||
20090088680, | |||
20090118800, | |||
20090118806, | |||
20090132042, | |||
20090187196, | |||
20090240314, | |||
20090248118, | |||
20100030298, | |||
20100190229, | |||
20100204638, | |||
20100240991, | |||
20100262212, | |||
20100268150, | |||
20110060377, | |||
20110087126, | |||
20110087311, | |||
20110105998, | |||
20110112179, | |||
20110125077, | |||
WO2011010257, | |||
WO942, | |||
WO10775, | |||
WO216942, | |||
WO4035030, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Nov 05 2010 | Greatbatch Ltd. | (assignment on the face of the patent) | / | |||
Dec 03 2010 | SEYMOUR, JOHN P | NeuroNexus Technologies | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 025970 | /0468 | |
Dec 03 2010 | KIPKE, DARYL R | NeuroNexus Technologies | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 025970 | /0468 | |
Dec 03 2010 | KONG, K C | NeuroNexus Technologies | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 025970 | /0468 | |
Dec 05 2010 | GULARI, MAYURACHAT NING | NeuroNexus Technologies | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 025970 | /0468 | |
Feb 16 2012 | NEURONEXUS TECHNOLOGIES, INC | MANUFACTURERS AND TRADERS TRUST COMPANY | GRANT OF SECURITY INTEREST | 028274 | /0763 | |
Aug 07 2014 | NeuroNexus Technologies | NEURONEXUS TECHNOLOGIES, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 033483 | /0537 | |
Oct 01 2015 | NEURONEXUS TECHNOLOGIES, INC | Greatbatch Ltd | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 036701 | /0156 | |
Oct 27 2015 | MICRO POWER ELECTRONICS, INC | MANUFACTURERS AND TRADERS TRUST COMPANY | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 036980 | /0482 | |
Oct 27 2015 | PRECIMED INC | MANUFACTURERS AND TRADERS TRUST COMPANY | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 036980 | /0482 | |
Oct 27 2015 | GREATBATCH-GLOBE TOOL, INC | MANUFACTURERS AND TRADERS TRUST COMPANY | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 036980 | /0482 | |
Oct 27 2015 | NEURONEXUS TECHNOLOGIES, INC | MANUFACTURERS AND TRADERS TRUST COMPANY | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 036980 | /0482 | |
Oct 27 2015 | ELECTROCHEM SOLUTIONS, INC | MANUFACTURERS AND TRADERS TRUST COMPANY | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 036980 | /0482 | |
Oct 27 2015 | GREATBATCH, INC | MANUFACTURERS AND TRADERS TRUST COMPANY | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 036980 | /0482 | |
Jan 08 2016 | Greatbatch Ltd | NEURONEXUS TECHNOLOGIES, INC | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNORS NAME PREVIOUSLY RECORDED ON REEL 037435 FRAME 0512 ASSIGNOR S HEREBY CONFIRMS THE ASSIGNMENT | 037579 | /0177 | |
Jan 08 2016 | GREATBATCH, LTD | NEURONEXUS TECHNOLOGIES, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 037435 | /0512 | |
Apr 18 2016 | MANUFACTURERS AND TRADERS TRUST COMPANY | ELECTROCHEM SOLUTIONS, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 039132 | /0773 | |
Apr 18 2016 | MANUFACTURERS AND TRADERS TRUST COMPANY | MICRO POWER ELECTRONICS, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 039132 | /0773 | |
Apr 18 2016 | MANUFACTURERS AND TRADERS TRUST COMPANY | NEURONEXUS TECHNOLOGIES, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 039132 | /0773 | |
Apr 18 2016 | MANUFACTURERS AND TRADERS TRUST COMPANY | QIG GROUP LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 039132 | /0773 | |
Apr 18 2016 | MANUFACTURERS AND TRADERS TRUST COMPANY | Greatbatch Ltd | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 039132 | /0773 | |
Sep 03 2021 | MANUFACTURERS AND TRADERS TRUST COMPANY AS ADMINISTRATIVE AGENT | PRECIMED INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 061659 | /0858 | |
Sep 03 2021 | MANUFACTURERS AND TRADERS TRUST COMPANY AS ADMINISTRATIVE AGENT | GREATBATCH-GLOBE TOOL, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 061659 | /0858 | |
Sep 03 2021 | MANUFACTURERS AND TRADERS TRUST COMPANY AS ADMINISTRATIVE AGENT | NEURONEXUS TECHNOLOGIES, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 061659 | /0858 | |
Sep 03 2021 | MANUFACTURERS AND TRADERS TRUST COMPANY AS ADMINISTRATIVE AGENT | ELECTROCHEM SOLUTIONS, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 061659 | /0858 | |
Sep 03 2021 | MANUFACTURERS AND TRADERS TRUST COMPANY AS ADMINISTRATIVE AGENT | GREATBATCH, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 061659 | /0858 | |
Sep 03 2021 | MANUFACTURERS AND TRADERS TRUST COMPANY AS ADMINISTRATIVE AGENT | MICRO POWER ELECTRONICS, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 061659 | /0858 |
Date | Maintenance Fee Events |
Jan 31 2018 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Apr 18 2022 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Date | Maintenance Schedule |
Oct 28 2017 | 4 years fee payment window open |
Apr 28 2018 | 6 months grace period start (w surcharge) |
Oct 28 2018 | patent expiry (for year 4) |
Oct 28 2020 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 28 2021 | 8 years fee payment window open |
Apr 28 2022 | 6 months grace period start (w surcharge) |
Oct 28 2022 | patent expiry (for year 8) |
Oct 28 2024 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 28 2025 | 12 years fee payment window open |
Apr 28 2026 | 6 months grace period start (w surcharge) |
Oct 28 2026 | patent expiry (for year 12) |
Oct 28 2028 | 2 years to revive unintentionally abandoned end. (for year 12) |